Concept

Potential beneficiary therapeutic effects of ROS amplifiers

  • ROS-induced inhibition of PMN-myeloid derived suppressor cells can inhibit cancer growth,
  • ROS-induced deactivation of T-cells and neutrophil extracellular traps (NETs) generation contributes to resolution of inflammation,
  • ROS-induced boosting of haematopoiesis can relieve myeloablation.